ISM6200

Advertisement

cGxPJobs Banner

Insilico Medicine Advances ISM6200 for Cancer Therapy

HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...

By cGxPwire Editor
April 13, 2026

Read More

Advertisement

cGxPJobs

Directory